{
  "title": "Special Episode: The Race to a Vaccine",
  "description": "<p>Large cap biotech analyst Matthew Harrison talks with Chief Cross-Asset Strategist Andrew Sheets to discuss the latest timeline for a coronavirus vaccine, hurdles to success and possible market reactions.&nbsp;&nbsp;</p>",
  "itunes:title": "Special Episode: The Race to a Vaccine",
  "itunes:episodeType": "full",
  "itunes:episode": 174,
  "itunes:summary": "Large cap biotech analyst Matthew Harrison talks with Chief Cross-Asset Strategist Andrew Sheets to discuss the latest timeline for a coronavirus vaccine, hurdles to success and possible market reactions.",
  "content:encoded": "<p>Large cap biotech analyst Matthew Harrison talks with Chief Cross-Asset Strategist Andrew Sheets to discuss the latest timeline for a coronavirus vaccine, hurdles to success and possible market reactions.&nbsp;&nbsp;</p>",
  "guid": "gid://art19-episode-locator/V0/K8-eOVo3PkawB1poMHKG2gYDKE5mglXHSF7y5UPS87s",
  "pubDate": "Thu, 04 Jun 2020 18:19:47 -0000",
  "itunes:explicit": "no",
  "itunes:image": "",
  "itunes:duration": "00:10:40",
  "enclosure": ""
}